Komori
Amvis Holdings (7071) · InitiativeAdvancedLatest Financial Results Presentation (2026-08-14): "Reframed"

Raising Capital Through the Stock Listing and Investing in New Facilities, Hiring and Systems

First written in FY2019. 18 of 21 entries say "Advanced", first in FY2020-Q1. Latest entry: 2026-08-14.

21entries
8years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2020-Q1 – FY2026-H12019: 12020: 420202021: 420212022: 420222023: 320232024: 220242025: 020252026: 32026
Same theme, other companies
Listing on the Tokyo Stock Exchange JASDAQ and Public Offering and Third-Party AllotmentA theme 46 companies write about · 0 as a headwind · 48 as a tailwind

The whole theme swung hardest in 2022: 10 of 35 companies on the "Worse" side.

8 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 46 companies compared. The sentences above are computed from all 46.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「Cash used in investing activities amounted to ¥3,228 million. This was mainly attributable to ¥3,232 million in expenditures for acquiring property, plant and equipment associated with opening new locations and ¥68 million in expenditures for lease deposits and guarantee deposits, among other factors.」

    The Company continued investing to expand openings, including ¥3,232 million in expenditures for acquiring property, plant and equipment for new locations.
  2. FY2024AdvancedAnnual report

    「Total capital expenditure and other investments for the consolidated fiscal year amounted to ¥15,940 million, mainly for the acquisition of buildings and land associated with opening 28 new facilities.」

    The Company made ¥15,940 million in capital expenditure in the fiscal year ended September 2024, primarily to open 28 new facilities.
  3. FY2024-Q1AdvancedAnnual report

    「Total assets at the end of the first quarter stood at ¥58,197 million, an increase of ¥2,637 million from the end of the previous consolidated fiscal year. This was mainly attributable to a ¥2,626 million decrease in cash and deposits due to tax payments and other factors, offset by a ¥384 million increase in accounts receivable from higher revenue, a ¥3,966 million increase in property, plant and equipment associated with opening new locations, and a ¥332 million increase in lease deposits and guarantee deposits, among other factors.」

    In connection with opening new locations, property, plant and equipment increased by ¥3,966 million and lease deposits and guarantee deposits increased by ¥332 million, while the Company proceeded with capital expenditure to expand openings. The report also lists the completion of openings at 6 facilities as major capital projects.
  4. FY2023-Q3AdvancedAnnual report

    「Total assets at the end of the third quarter stood at ¥50,866 million, an increase of ¥9,099 million from the end of the previous consolidated fiscal year. This was mainly attributable to a ¥1,185 million increase in accounts receivable from higher revenue, a ¥6,585 million increase in property, plant and equipment associated with opening new locations, and a ¥591 million increase in lease deposits and guarantee deposits, among other factors.」

    In connection with opening new locations, property, plant and equipment increased by ¥6,585 million and lease deposits and guarantee deposits increased by ¥591 million. The Company continues to make capital expenditure to expand openings.
  5. FY2023-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥5,290 million. This was mainly attributable to ¥5,310 million in expenditures for acquiring property, plant and equipment associated with opening new locations and ¥419 million in expenditures for lease deposits and guarantee deposits, partly offset by ¥400 million in proceeds from the transfer of a business.」

    The Company proceeded with investment to expand openings, including ¥5,310 million in expenditures for acquiring property, plant and equipment for new locations.
  6. FY2023-Q1AdvancedAnnual report

    「This was mainly attributable to a ¥963 million decrease in cash and deposits due to tax payments and other factors, offset by a ¥453 million increase in accounts receivable from higher revenue, a ¥2,419 million increase in property, plant and equipment associated with opening new locations, and a ¥308 million increase in lease deposits and guarantee deposits, among other factors.」

    In connection with opening new locations, property, plant and equipment increased by ¥2,419 million and lease deposits and guarantee deposits increased by ¥308 million. In addition, opening plans were finalised for 5 facilities—Anjo, Oimachi, Osone, Kanazawa and Toyota—from September through November 2023, with total post-completion capacity expected to increase by 248 beds.
  7. FY2022AdvancedAnnual report

    「Total capital expenditure and other investments for the consolidated fiscal year amounted to ¥6,057 million, mainly for the acquisition of buildings and land associated with opening 16 new facilities.」

    The Company made ¥6,057 million in capital expenditure in connection with opening 16 new facilities. Cash used in investing activities was ¥7,751 million, while proceeds from long-term borrowings were ¥4,573 million.
  8. FY2022-Q3AdvancedAnnual report

    「This was mainly attributable to a ¥1,141 million increase in accounts receivable from higher revenue, a ¥5,356 million increase in property, plant and equipment associated with opening new locations, and a ¥414 million increase in lease deposits and guarantee deposits, among other factors.」

    In connection with opening new locations, property, plant and equipment increased by ¥5,356 million and lease deposits and guarantee deposits increased by ¥414 million. The capital expenditure plan called for openings in Fuji, Kasukabe, Numazu and other locations from November 2022 through August 2023, with total post-completion capacity expected to increase by 45 to 77 beds.
  9. FY2022-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥4,021 million. This was mainly attributable to ¥3,645 million in expenditures for acquiring property, plant and equipment associated with opening new locations and ¥326 million in expenditures for lease deposits and guarantee deposits, among other factors.」

    The Company proceeded with investment to expand openings, including ¥3,645 million in expenditures for acquiring property, plant and equipment for new locations. Total assets also increased by ¥4,920 million from the end of the previous consolidated fiscal year.
  10. FY2022-Q1AdvancedAnnual report

    「This was mainly attributable to a ¥605 million decrease in cash and deposits due to tax payments and other factors, offset by a ¥404 million increase in accounts receivable from higher revenue and a ¥2,152 million increase in property, plant and equipment from the acquisition of fixed assets associated with opening new locations, among other factors.」

    The acquisition of property, plant and equipment in connection with opening new locations increased by ¥2,152 million, and the Company proceeded with capital expenditure to expand openings.
  11. FY2021AdvancedAnnual report

    「Total capital expenditure and other investments for the consolidated fiscal year amounted to ¥6,250 million, mainly for the acquisition of buildings and land associated with opening 13 new facilities.」

    The Company raised ¥8,548 million through a public offering of new shares and ¥4,890 million through long-term borrowings, and made ¥6,250 million in capital expenditure, primarily to open 13 new facilities.
  12. FY2021-Q3AdvancedAnnual report

    「Total assets at the end of the third quarter stood at ¥29,377 million, an increase of ¥12,857 million from the end of the previous consolidated fiscal year. This was mainly attributable to increases of ¥7,083 million in cash and deposits from the issuance of new shares and other transactions, ¥944 million in accounts receivable from higher revenue, and ¥4,287 million in property, plant and equipment from the acquisition of buildings and structures associated with opening new locations, among other factors.」

    Cash and deposits increased through the issuance of new shares and other transactions, while the Company proceeded with acquiring property, plant and equipment for new locations. The public offering of new shares increased both stated capital and capital surplus by ¥4,294 million.
  13. FY2021-Q2AdvancedAnnual report

    「Funds provided by financing activities amounted to ¥9,865 million. This was mainly attributable to ¥8,542 million in proceeds from the issuance of shares and ¥2,925 million in proceeds from long-term borrowings associated with opening new locations, partly offset by a net decrease of ¥701 million in short-term borrowings and ¥726 million in repayments of long-term borrowings, among other factors.」

    The Company raised ¥8,542 million through a public offering of new shares and proceeded with long-term borrowing and the acquisition of property, plant and equipment in connection with opening new locations. Investing activities included ¥2,748 million in expenditures for acquiring property, plant and equipment for new locations.
  14. FY2021-Q1AdvancedAnnual report

    「This was mainly attributable to a ¥343 million increase in accounts receivable from higher revenue and a ¥1,563 million increase in property, plant and equipment from the acquisition of buildings and structures, construction in progress and other assets associated with opening new locations, among other factors.」

    The acquisition of property, plant and equipment in connection with opening new locations increased by ¥1,563 million, and the Company proceeded with capital expenditure for growth. Borrowings associated with opening and investing in new locations also increased by ¥1,500 million.
  15. FY2020AdvancedAnnual report

    「Total capital expenditure and other investments for the consolidated fiscal year amounted to ¥3,178.550 million, mainly for the acquisition of buildings and land associated with opening 9 new facilities.」

    The Company made ¥3,178.550 million in capital expenditure in connection with opening 9 new facilities. Cash used in investing activities was ¥4,895.877 million, while proceeds from the issuance of shares were ¥2,987.721 million.
  16. FY2020-Q3AdvancedAnnual report

    「Total assets at the end of the third quarter stood at ¥13,609.090 million, an increase of ¥6,611.845 million from the end of the previous consolidated fiscal year. This was mainly attributable to increases of ¥2,448.969 million in cash and deposits from the public offering and third-party allotment conducted in connection with the listing on the Tokyo Stock Exchange JASDAQ, including the third-party allotment associated with the over-allotment offering, ¥515.228 million in accounts receivable from higher revenue, and ¥3,370.936 million in property, plant and equipment from the acquisition of buildings, tools, fixtures, equipment and leased assets in connection with opening new locations, among other factors.」

    Backed by funds raised through the public offering and third-party allotment in connection with the listing, the Company proceeded with acquiring property, plant and equipment for new locations, documenting its capital expenditure.
  17. FY2020-Q2AdvancedAnnual report

    「This was mainly attributable to increases of ¥2,177.748 million in cash and deposits from the public offering and third-party allotment conducted in connection with the listing on the Tokyo Stock Exchange JASDAQ, including the third-party allotment associated with the over-allotment offering, and ¥2,159.432 million in property, plant and equipment from the acquisition of buildings, tools, fixtures, equipment and leased assets in connection with opening new locations, among other factors.」

    Following the raising of funds through the public offering and third-party allotment, the Company proceeded with acquiring property, plant and equipment in connection with opening new locations, recording ¥3,001.808 million in proceeds from the issuance of shares and ¥1,763.739 million in capital expenditure.
  18. FY2020-Q1AdvancedAnnual report

    「This was mainly attributable to increases of ¥2,264.283 million in cash and deposits from the public offering and third-party allotment conducted in connection with the listing on the Tokyo Stock Exchange JASDAQ, including the third-party allotment associated with the over-allotment offering, ¥210.424 million in accounts receivable from higher revenue, and ¥1,128.500 million in property, plant and equipment from the acquisition of buildings, tools, fixtures, equipment and leased assets in connection with opening new locations, among other factors.」

    The Company conducted a public offering and third-party allotment in connection with its JASDAQ listing and allocated the funds raised to capital expenditure, including opening new locations.
  19. FY2019First statedAnnual report

    「Use of proceeds: Together with the proceeds from the third-party allotment resolved by the Board of Directors on the same date as this public offering, with 6 November 2019 as the payment date, the proceeds will be allocated as capital expenditure to fund new openings for the Group's Ishinkan business, as working capital to cover employee recruitment costs, network system construction costs and the development of various operating systems, and to repay borrowings and other debt.」

    The Company outlined plans to allocate funds raised through its 9 October 2019 JASDAQ listing, public offering and third-party allotment to facility openings, recruitment, system development and debt repayment.
Moved together

"Expanding the Scale and Number of Medical Hospice Facilities" moved the same way as this thread, in the same document, in 18 of its 21 moves.

181815555★123456
  1. ★This thread
  2. 1Expanding the Scale and Number of Medical Hospice Facilities18×
  3. 2Growth in Facilities, Capacity and Financial Results18×
  4. 3Sustained Improvement in Revenue, Profit, Profitability and Financial Stability15×
  5. 4A Dominant Strategy in Major Cities and a High-Market-Share Strategy in Regional Cities5×
  6. 5Entering the Business of Strengthening and Revitalizing Regional Hospitals and Hospital Beds5×
  7. 6Expanding the Business Scope Through Adjacent and New Businesses5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Amvis Holdings yet. It last moved in the Financial Results Presentation of 2026-08-14: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Raising Capital Through the Stock Listing and Investing in New Facilities, Hiring and Systems | Amvis Holdings,Inc. (7071) | Komori